Upcoming Events
  1. Consumer training workshops

    July 7 @ 12:30 pm - 2:00 pm
  2. Conducting systematic reviews: A short course for thoracic oncology nurses

    August 5 @ 6:30 pm
  3. 6th ALTG Lung Cancer Preceptorship

    October 23 @ 10:00 am - October 24 @ 3:30 pm
  4. ALTG open MAC and SAC meetings

    November 20

ALTG 11/002 Temozolomide and PARPI as 2LC for SCLC

Phase I/II study of temozolomide and PARP (Poly ADP ribose polymerase) inhibitor as a second line chemotherapy for SCLC. This study concept is on hold and will be reviewed once the results of an ongoing Phase 1 study at UCLA exploring the combination are available.

Any further enquiries regarding this trial should be directed to the CTC Clinical Lead A/Prof Martin Stockler, atmartin.stockler@sydney.edu.au